Thai PBS Thai PBS
BioNTech produces 10 times more antibodies than Sinovac: Hong Kong study

BioNTech produces 10 times more antibodies than Sinovac: Hong Kong study

13 Sept 08:47 Key points summarised by AI
  • A Hong Kong study revealed that BioNTech vaccine recipients developed ten times more antibodies than those who received China's Sinovac.
  • Researchers indicate that this substantial difference in antibody concentration could lead to significant variations in overall vaccine effectiveness.
  • Despite the findings, experts still recommend Sinovac if other options are unavailable, stressing that any vaccination offers better protection than none.
  • The study suggests that 'alternative strategies,' like earlier booster shots, may be necessary to enhance protection for individuals vaccinated with Sinovac.
Read full article
World 1/2
Skip > Skip >